Abstract
Because of the increasing use of IFN-αin both induction and maintenance therapy for multiple myeloma (MM), its effect on growth and apoptosis of myeloma cells is important to consider. To investigate the role of IFN-αon the growth of myeloma cells, we have studied its effects on the response of interleukin 6 (IL-6)-dependent myeloma cell line (ANBL6) and IL-6-independent myeloma cell line (C2E3) in the presence of IL-6 and dexamethasone (Dex). We found that although IFN-αis a potent inhibitor of proliferation, it has only a minimal effect on induction of apoptosis. Moreover, we found IFN-α as well as IL-6 can significantly suppress dexamethasone-induced apoptosis. The suppression of apoptosis is concurrent with the induction of both AP-1 and STAT binding activity. We also found that IL-6 but not IFN-αup-regulates Bcl-XL expression. However, IL-6-mediated Bcl-XL expression is suppressed in the presence of Dex. Therefore, the expression of Bcl-XL does not account for the protection of Dex-induced apoptosis by IFN-αand IL-6. Taken together, our results suggest that IFN-αmay counteract the beneficial effects of corticosteroids or perhaps other apoptosis inducing agents in the treatment of myeloma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, P., Oken, M. & Van Ness, B. Interferon-α protects myeloma cell lines from dexamethasone-induced apoptosis. Leukemia 13, 473–480 (1999). https://doi.org/10.1038/sj.leu.2401334
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401334
Keywords
This article is cited by
-
Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22
Hepatology International (2013)
-
Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1
Cell Death & Differentiation (2000)